BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
BRAF
,
Apoptosis
,
Leukemia
,
Lymphocyte
,
Early pregnancy factor
,
Acetaminophen
,
rs2300478
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Death-like domain superfamily
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Accumbens
Leukocyte (polymorphonuclear) of peripheral blood
Neutrophil of bone marrow
Putamen
Lymph nodes
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Disease due to Togaviridae
Coronavirus infection
Eczema
Sepsis due to Escherichia coli
Contact dermatitis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Carrageenan
A 443654
GSK690693
CGP 60474
niguldipine
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MIR122
TBC1D23
PCDH11X
RPS6
NR5A1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Tumor formation by ATG5 KO cells
Glomerulonephrotic and healthy tissue from C57BL6.MRLc1 congenic mice
Dicer1 knockout gene expression during Schwann cell development
miRNA expression profiles from osteosarcoma samples and cell lines
The Cancer Genome Atlas (TCGA) mRNA-Seq expression of aggregated samples for several cancers
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Death-like domain superfamily
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Novel Biomarkers in Inflammatory Bowel Disease
Pembrolizumab (MK-3475) in MM Patients With Residual Disease
Pembrolizumab And Tamoxifen Among Women With Advanced Hormone Receptor Positive Breast Cancer And Es…
Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
Pembrolizumab in First Line Treatment of Advanced NSCLC Patients With PD-L1 Low Tumors.
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ